These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1860683)

  • 21. Dysplasia and colorectal cancer in a patient with ulcerative colitis and primary sclerosing cholangitis: a case report and a short review of the literature.
    Chaparro M; Trapero-Marugán M; Guijarro M; López C; Moreno-Otero R; Gisbert JP
    J Crohns Colitis; 2013 Mar; 7(2):e61-5. PubMed ID: 22552273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical markers of bone metabolism in mild ankylosing spondylitis and their relationship with bone mineral density and vertebral fractures.
    Mitra D; Elvins DM; Collins AJ
    J Rheumatol; 1999 Oct; 26(10):2201-4. PubMed ID: 10529140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in bone mineral density after surgical intervention for primary hyperparathyroidism.
    Dy BM; Grant CS; Wermers RA; Kearns AE; Huebner M; Harmsen WS; Thompson GB; Farley DR; Richards ML
    Surgery; 2012 Dec; 152(6):1051-8. PubMed ID: 23040710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males.
    Di Somma C; Colao A; Di Sarno A; Klain M; Landi ML; Facciolli G; Pivonello R; Panza N; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 1998 Mar; 83(3):807-13. PubMed ID: 9506732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone mineral density among postmenopausal Saudi women.
    Sadat-Ali M; Al-Habdan IM; Al-Mulhim FA; El-Hassan AY
    Saudi Med J; 2004 Nov; 25(11):1623-5. PubMed ID: 15573189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone disease in calcium stone forming patients.
    Heilberg IP; Martini LA; Szejnfeld VL; Carvalho AB; Draibe SA; Ajzen H; Ramos OL; Schor N
    Clin Nephrol; 1994 Sep; 42(3):175-82. PubMed ID: 7994936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does colitis associated with primary sclerosing cholangitis represent an actual subset of ulcerative colitis?
    Oshitani N; Jinno Y; Sawa Y; Nakamura S; Matsumoto T; Nishiguchi S; Seki S; Higuchi K; Arakawa T
    Hepatogastroenterology; 2003; 50(54):1830-5. PubMed ID: 14696415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of ursodeoxycholic acid on the kinetics of cholic acid and chenodeoxycholic acid in patients with primary sclerosing cholangitis.
    Rudolph G; Endele R; Senn M; Stiehl A
    Hepatology; 1993 Jun; 17(6):1028-32. PubMed ID: 8514251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Primary sclerosing cholangitis, ulcerative colitis and type 1 diabetes mellitus].
    Gluch J; Glaser J
    Z Gastroenterol; 1999 Aug; 37(8):735-8. PubMed ID: 10494609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of osteomalacia in chronic cholestatic liver disease.
    Stellon AJ; Webb A; Compston J; Williams R
    Bone; 1986; 7(3):181-5. PubMed ID: 3768195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Systematic Review and Meta-Analysis on Metabolic Bone Disease in Patients with Primary Sclerosing Cholangitis.
    Ionele CM; Turcu-Stiolica A; Subtirelu MS; Ungureanu BS; Cioroianu GO; Rogoveanu I
    J Clin Med; 2022 Jun; 11(13):. PubMed ID: 35807091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteosarcopenia in autoimmune cholestatic liver diseases: Causes, management, and challenges.
    Pugliese N; Arcari I; Aghemo A; Lania AG; Lleo A; Mazziotti G
    World J Gastroenterol; 2022 Apr; 28(14):1430-1443. PubMed ID: 35582674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholestatic Liver Disease: Current Treatment Strategies and New Therapeutic Agents.
    Hasegawa S; Yoneda M; Kurita Y; Nogami A; Honda Y; Hosono K; Nakajima A
    Drugs; 2021 Jul; 81(10):1181-1192. PubMed ID: 34142342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventative care in cholestatic liver disease: Pearls for the specialist and subspecialist.
    Malik A; Kardashian AA; Zakharia K; Bowlus CL; Tabibian JH
    Liver Res; 2019 Jun; 3(2):118-127. PubMed ID: 32042471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary sclerosing cholangitis: diagnostic and management challenges.
    Sirpal S; Chandok N
    Clin Exp Gastroenterol; 2017; 10():265-273. PubMed ID: 29138587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diffusion-weighted MRI for detection of hepatic osteodystrophy in primary sclerosing cholangitis: a comparison study with dual-energy X-ray absorptiometry.
    Keller S; Ittrich H; Schramm C; Lohse AW; Amling M; Adam G; Yamamura J
    Jpn J Radiol; 2016 Oct; 34(10):677-683. PubMed ID: 27492220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Review of the Challenges Associated with the Diagnosis and Therapy of Primary Sclerosing Cholangitis.
    Saadi M; Yu C; Othman MO
    J Clin Transl Hepatol; 2014 Mar; 2(1):45-52. PubMed ID: 26357617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of fragility fractures on health-related quality of life in patients with primary sclerosing cholangitis.
    Raszeja-Wyszomirska J; Kucharski R; Zygmunt M; Safranow K; Miazgowski T
    Hepat Mon; 2015 Apr; 15(4):e25539. PubMed ID: 25972904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wilson's disease: An endocrine revelation.
    Kapoor N; Shetty S; Thomas N; Paul TV
    Indian J Endocrinol Metab; 2014 Nov; 18(6):855-7. PubMed ID: 25364683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients, cells, and organelles: the intersection of science and serendipity.
    Larusso NF
    Hepatology; 2011 May; 53(5):1417-26. PubMed ID: 21413050
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.